1. Budget impact of introducing subcutaneous vedolizumab as a maintenance therapy in biologic-naïve and biologic-experienced patients with ulcerative colitis in France. (7th February 2023) Authors: Oppe, Mark; Muresan, Bogdan; Chan, Katie; Radu, Xenia; Schultz, Bob G.; Turpin, Robin S.; Nucit, Arnaud; Fenu, Elisabetta Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 23:Number 2(2023) Page Start: 205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Discovery of the pan-genotypic hepatitis C virus NS3/4A protease inhibitor voxilaprevir (GS-9857): A component of Vosevi®. Issue 16 (15th August 2019) Authors: Taylor, James G.; Zipfel, Sheila; Ramey, Kyla; Vivian, Randy; Schrier, Adam; Karki, Kapil K.; Katana, Ashley; Kato, Darryl; Kobayashi, Tetsuya; Martinez, Ruben; Sangi, Michael; Siegel, Dustin; Tran, Chinh V.; Yang, Zheng-Yu; Zablocki, Jeff; Yang, Cheng Y.; Wang, Yujin; Wang, Kelly; Chan, Katie; B... Journal: Bioorganic & medicinal chemistry letters Issue: Volume 29:Issue 16(2019) Page Start: 2428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens. Issue 8 (1st August 2017) Authors: Hart, Traver; Tong, Amy Hin Yan; Chan, Katie; Van Leeuwen, Jolanda; Seetharaman, Ashwin; Aregger, Michael; Chandrashekhar, Megha; Hustedt, Nicole; Seth, Sahil; Noonan, Avery; Habsid, Andrea; Sizova, Olga; Nedyalkova, Lyudmila; Climie, Ryan; Tworzyanski, Leanne; Lawson, Keith; Sartori, Maria Augus... Journal: G3 Issue: Volume 7:Issue 8(2017) Page Start: 2719 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗